Tsuyoshi Terashima

No ORCID on file · 1 paper in corpus · active 2021

Study types

  • article 1

Condition tags

  • adenomyosis 1
article 2021
BMC women's health ·doi:10.1186/s12905-021-01442-x

Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyos…